PTGX icon

Protagonist Therapeutics

136 hedge funds and large institutions have $522M invested in Protagonist Therapeutics in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 42 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$10.4M
Puts
$2.59M
Net Calls
Net Calls Change

Top Sellers

1 -$29.9M
2 -$24.2M
3 -$9.64M
4
RI
RTW Investments
New York
-$6.38M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
-$2.83M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$41.4M
2
$39.8M
3
$39.8M
4
$39.2M
5
$33.8M
6
$26.7M
7
$26.6M
8
$25.8M
9
$25.7M
10
$15.9M
11
$14.7M
12
$10.1M
13
$10.1M
14
$9.6M
15
$9.51M
16
$8.37M
17
$6.73M
18
$6.58M
19
$5.72M
20
$5.68M
21
$5.59M
22
$5.37M
23
$4.74M
24
$4.57M
25
$4.44M